Dose-extension group:ZS805 injection

2 trials

Sponsors

West China Hospital,Sichuan University, West China Hospital, Sichuan University

Conditions

Fabry disease

Early Phase 1

A study to evaluate the safety and efficacy of ZS805 adeno-associated virus vector expressing human a -galactosidase A in adult patients with Fabry disease.

Active, not recruitingChiCTR2300073886

West China Hospital,Sichuan UniversityFabry disease

Start: 2023-08-31Updated: 2023-07-30

Phase 2

A Phase I/II study to evaluate the safety, tolerability and efficacy of ZS805 in the treatment of patients with Fabry disease

Active, not recruitingChiCTR2400094356

West China Hospital, Sichuan UniversityFabry disease

Start: 2024-12-25Updated: 2025-01-06